Day: October 30, 2025

This press release corrects and replaces the company’s press release issued today, 10/29, at 4:15 p.m. ET in order to correct a typographical error in the first sub-bullet under “WVE-007 (GalNAc-siRNA)” – “Next steps.” Dose-dependent mean reductions of Activin E of up to 85% one month post single dose of WVE-007 in INLIGHT clinical trial, exceeding levels that led to weight loss in preclinical models; WVE-007 is generally safe and well tolerated to date Activin E reduction in lowest dose cohort of INLIGHT was sustained through 6 months, supporting once or twice a year dosing Multiple clinical data updates from INLIGHT, including body composition and body weight, are anticipated starting in 4Q 2025 Additional updates included announcement of WVE-008, PNPLA3 RNA editing candidate for liver disease, with CTA submission anticipated in 2026 Preclinical...

GUADALAJARA, Mexico, Oct. 29, 2025 (GLOBE NEWSWIRE) — Grupo Aeroportuario del Pacífico, S.A.B. de C.V. (NYSE: PAC; BMV: GAP) (“the Company” or “GAP”) reports that following the passage of Hurricane Melissa over Jamaica, Kingston Airport resumed operations today at 4:00 p.m. (local time) for humanitarian aid flights. Commercial operations will resume tomorrow, October 30, 2025, at 7:00 a.m. All critical infrastructure including the runway, terminal building, boarding bridges, security systems, and essential equipment, has been inspected in accordance with international safety protocols and is in suitable condition for aircraft operations and passenger services. Kingston Airport remains in close coordination with airport authorities, airlines, and humanitarian organizations to ensure a safe and orderly restoration of operations,...

Hong Kong, Oct. 29, 2025 (GLOBE NEWSWIRE) — Raytech Holding Limited (NASDAQ: RAY) (the “Company”), a Hong Kong-headquartered company specializing in design, sourcing and wholesale of personal care electrical appliances for international brand owners, today announced that the Company’s board of directors approved on October 17, 2025 that the authorized, issued, and outstanding shares of the Company be consolidated on an 16-for-1 ratio (the “Share Consolidation”), with the marketplace effective date of November 7, 2025. The objective of the share consolidation is to enable the Company to regain compliance with Nasdaq Marketplace Rule 5550(a)(2), which pertains to the minimum bid price requirement, and maintain its listing on the Nasdaq Capital Market. Beginning with the opening of trading on November 7, 2025, the Company’s ordinary...

EASTON, Md., Oct. 29, 2025 (GLOBE NEWSWIRE) — TeraWulf Inc. (Nasdaq: WULF) (“TeraWulf” or the “Company”), a leading owner and operator of vertically integrated, low-carbon digital infrastructure, today announced the upsize and pricing of its offering of $900 million aggregate principal amount of 0.00% Convertible Senior Notes due 2032 (the “Convertible Notes”). The Convertible Notes will be sold in a private offering to persons reasonably believed to be qualified institutional buyers in reliance on Rule 144A under the Securities Act of 1933, as amended (the “Securities Act”). Key Elements of the Transaction:The offering comprises $900 million aggregate principal amount of 0.00% Convertible Senior Notes due 2032 (with a 37.5% conversion premium). TeraWulf has granted the initial purchasers of the Convertible Notes a 13-day option...

ROCKVILLE, Md. and SUZHOU, China, Oct. 29, 2025 (GLOBE NEWSWIRE) — Ascentage Pharma Group International (NASDAQ: AAPG; HKEX: 6855) (“Ascentage Pharma” or the “Company”), a global, commercial stage, integrated biopharmaceutical company engaged in the discovery, development and commercialization of novel, differentiated therapies to address unmet medical needs in cancer, announced today that the Company’s management is scheduled to participate in the following investor conferences in November 2025.Goldman Sachs APAC Healthcare Corporate Day 2025: One-on-one and group investor meetings on November 5 Stifel 2025 Healthcare Conference: Presentation on November 13 at 2:40 pm ESTAbout Ascentage Pharma Group International Ascentage Pharma Group International (NASDAQ: AAPG; HKEX: 6855) (“Ascentage Pharma” or the “Company”) is...

VANCOUVER, British Columbia, Oct. 29, 2025 (GLOBE NEWSWIRE) — Rubicon Organics Inc. (TSXV: ROMJ) (OTCQX: ROMJF) (“Rubicon Organics” or the “Company”), a licensed producer focused on cultivating and selling organic certified and premium cannabis products, will release its financial results for the three and nine months ended September 30, 2025 (“Q3 2025”) after market close on Wednesday, November 12, 2025. The Company will host a conference call to discuss Q3 2025 results on Thursday, November 13, 2025. Conference call details are as follows:Time: 7:00 AM PT / 10:00 AM ETConference ID: 89693Local dial-in: +1 (289) 514 5100Toll Free N. America: +1 (800) 717 1738Webcast: Rubicon Organics Q3 2025 Earnings Call Registration ABOUT RUBICON ORGANICS INC. Rubicon Organics is the Canadian leader in certified organic...